Millennium Takeda Pharmaceutical Biotech Company News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute can help patients and their physicians weigh benefits and risks of each option.

United statesDana farber kennethc andersonNikhil munshiEmily hendersonPaulg richardsonNational cancer instituteRj corman multiple myeloma research fundJerome lipper multiple myeloma centerMarrow transplant clinical trials networkMillennium takeda pharmaceutical biotech companyJerome lipper multiple myeloma center at dana farberLebow institute for myeloma therapeuticsDana farber cancer instituteBlood instituteNational heartAnnual meeting

Triplet induction, autologous HSCT, lenalidomide maintenance extend PFS in multiple myeloma

CHICAGO — Lenalidomide, bortezomib and dexamethasone plus autologous stem cell transplantation and lenalidomide-based maintenance conferred a significant PFS benefit among patients with newly diagnosed multiple myeloma.However, no OS benefit had been observed at the time of data cutoff, according to results of the phase 3 DETERMINATION trial presented during ASCO Annual Meeting and

United statesCelgene bristol myers squibbSecura bioNitya nathwaniJulier gralowJennifer southallPaulg richardsonInternational staging systemJazz pharmaceuticalsRj corman multiple myeloma research fundBristol myers squibbMarrow transplant clinical trials networkMillennium takeda pharmaceutical biotech companyBiotech companyMultiple myeloma research fundKaryopharm therapeutics

Improved progression-free survival in multiple myeloma patients following three-drug therapy with autologous stem cell transplant

Improved progression-free survival in multiple myeloma patients following three-drug therapy with autologous stem cell transplant
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesDana farber cancer instituteDana farber kennethc andersonNikhil munshiPaulg richardsonBlood disorders centerNational cancer instituteJerome lipper multiple myeloma centerRj corman multiple myeloma research fundMarrow transplant clinical trials networkMillennium takeda pharmaceutical biotech companyJerome lipper multiple myeloma center at dana farberDana farber brigham cancer centerLebow institute for myeloma therapeuticsBlood instituteNational heart

Improved progression-free survival in patients with multiple myeloma following three-drug therapy with autologous stem cell

Improved progression-free survival in patients with multiple myeloma following three-drug therapy with autologous stem cell
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesDana farber kennethc andersonNikhil munshiPaulg richardsonNational cancer instituteRj corman multiple myeloma research fundJerome lipper multiple myeloma centerMarrow transplant clinical trials networkMillennium takeda pharmaceutical biotech companyJerome lipper multiple myeloma center at dana farberLebow institute for myeloma therapeuticsDana farber cancer instituteBlood instituteNational heartAnnual meetingAmerican society